$1.39 Billion is the total value of RTW INVESTMENTS, LP's 40 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 36.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | $289,448,000 | +12.1% | 14,969,744 | 0.0% | 20.88% | -15.1% | |
| RGNX | Buy | Regenxbio Inc | $149,208,000 | +166.2% | 2,079,555 | +10.7% | 10.76% | +101.7% |
| PTCT | Sell | Ptc Therapeutics Inc | $137,406,000 | +22.7% | 4,073,690 | -1.6% | 9.91% | -7.0% |
| SRPT | Buy | Sarepta Therapeutics Inc | $129,345,000 | +153.6% | 978,551 | +42.2% | 9.33% | +92.2% |
| ARWR | Buy | Arrowhead Pharmaceuticals In | $112,874,000 | +436.8% | 8,299,542 | +184.6% | 8.14% | +306.8% |
| DRNA | Buy | Dicerna Pharmaceuticals Inc | $61,799,000 | +28.5% | 5,044,813 | +0.3% | 4.46% | -2.6% |
| BMY | Sell | Bristol Myers Squibb Co | $50,009,000 | -27.9% | 903,672 | -17.6% | 3.61% | -45.3% |
| LIVN | Buy | Livanova PLC | $43,022,000 | +247.2% | 431,000 | +207.9% | 3.10% | +163.2% |
| LJPC | Buy | La Jolla Pharmaceutical Co | $39,259,000 | +17.4% | 1,345,881 | +19.9% | 2.83% | -11.0% |
| ACHN | Buy | Achillion Pharmaceuticals In | $38,324,000 | -23.5% | 13,541,997 | +0.3% | 2.76% | -42.0% |
| ABUS | Buy | Arbutus Biopharma Corp | $37,708,000 | +46.4% | 5,165,499 | +0.3% | 2.72% | +11.0% |
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $34,688,000 | +18.3% | 352,200 | +43.0% | 2.50% | -10.4% |
| MASI | Buy | Masimo Corp | $24,368,000 | +19.4% | 249,543 | +7.6% | 1.76% | -9.5% |
| SLDB | Solid Biosciences Inc | $22,753,000 | +393.3% | 675,771 | 0.0% | 1.64% | +273.8% | |
| VCEL | Buy | Vericel Corp | $21,514,000 | +4.6% | 2,217,916 | +7.3% | 1.55% | -20.7% |
| AGEN | Buy | Agenus Inc | $21,282,000 | -51.5% | 9,375,451 | +0.7% | 1.54% | -63.2% |
| QGEN | New | Qiagen NV | $19,143,000 | – | 529,385 | +100.0% | 1.38% | – |
| QURE | Buy | Uniqure NV | $15,474,000 | +61.9% | 409,370 | +0.7% | 1.12% | +22.6% |
| CORI | Buy | Corium Intl Inc | $15,405,000 | -29.7% | 1,923,217 | +0.7% | 1.11% | -46.7% |
| ILMN | New | Illumina Inc | $13,869,000 | – | 49,658 | +100.0% | 1.00% | – |
| MYOK | Buy | Myokardia Inc | $12,978,000 | +2.4% | 261,395 | +0.7% | 0.94% | -22.4% |
| VRAY | Buy | Viewray Inc | $10,201,000 | +16.8% | 1,474,156 | +8.5% | 0.74% | -11.4% |
| PTE | New | Polarityte Inc | $10,044,000 | – | 426,670 | +100.0% | 0.72% | – |
| CDNA | Buy | Caredx Inc | $9,358,000 | +109.4% | 764,532 | +36.4% | 0.68% | +58.8% |
| BVX | Buy | Bovie Medical Corp | $9,057,000 | +57.8% | 2,082,137 | +7.8% | 0.65% | +19.6% |
| ECOR | New | Electrocore Inc | $8,338,000 | – | 505,000 | +100.0% | 0.60% | – |
| NVTRQ | Sell | Nuvectra Corp | $7,864,000 | +19.1% | 383,030 | -24.5% | 0.57% | -9.7% |
| VIVE | Buy | Viveve Med Inc | $7,782,000 | -16.9% | 2,861,023 | +11.9% | 0.56% | -37.0% |
| ODT | Buy | Odonate Therapeutics Inc | $6,102,000 | +15.1% | 276,368 | +0.7% | 0.44% | -12.9% |
| STIM | New | Neuronetics Inc | $5,056,000 | – | 190,000 | +100.0% | 0.36% | – |
| FIXX | Buy | Homology Medicines Inc | $4,619,000 | +9.8% | 226,431 | +0.6% | 0.33% | -16.8% |
| NVAX | Sell | Novavax Inc | $3,543,000 | -38.1% | 2,644,346 | -3.0% | 0.26% | -53.0% |
| New | Vivus Inc 4.5 05/01/2020note 4.500% 5/0 | $3,140,000 | – | 4,000,000 | +100.0% | 0.23% | – | |
| PTI | Sell | Proteostasis Therapeutics In | $3,006,000 | -42.7% | 1,077,408 | -2.5% | 0.22% | -56.5% |
| ARGX | Buy | Argenx Sesponsored adr | $2,118,000 | +3.4% | 25,559 | +0.4% | 0.15% | -21.5% |
| NVUS | Buy | Novus Therapeutics Inc | $2,113,000 | +39.7% | 301,799 | +0.6% | 0.15% | +5.6% |
| TPIV | New | Tapimmune Inc | $1,886,000 | – | 200,000 | +100.0% | 0.14% | – |
| BLCM | New | Bellicum Pharmaceuticals Inc | $1,109,000 | – | 150,289 | +100.0% | 0.08% | – |
| ADVM | Buy | Adverum Biotechnologies Inc | $935,000 | -8.0% | 176,372 | +0.7% | 0.07% | -30.9% |
| MOTS | Sell | Motus Gi Hldgs Inc | $428,000 | -19.4% | 59,478 | -49.8% | 0.03% | -39.2% |
| OSUR | Exit | OraSure Technologies Inc | $0 | – | -117,291 | -100.0% | -0.19% | – |
| Exit | VIVUS INCnote 4.500% 5/0 | $0 | – | -4,000,000 | -100.0% | -0.24% | – | |
| ARMO | Exit | Armo Biosciences Inc | $0 | – | -413,892 | -100.0% | -1.33% | – |
| EW | Exit | Edwards Lifesciences Corp | $0 | – | -145,246 | -100.0% | -1.93% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -456,921 | -100.0% | -2.10% | – |
| AVXS | Exit | Avexis Inc | $0 | – | -236,425 | -100.0% | -2.78% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.